Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04753216
Title Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Bevacizumab + MM-398

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.